QuidelOrtho
QDEL
$45.92
Share price
-2.93%
Change (1 day)
-28.12%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.
Operating Margin for QuidelOrtho (QDEL)
Operating Margin as of March 2025 (TTM): -76.59%
According to QuidelOrtho's latest financial reports and stock price the company's current Operating Margin is -76.59%. At the end of 2024 the company had an Operating Margin of -76.59%.
Operating Margin history for QuidelOrtho from 2001 to 2024
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | -76.59% | 7790.37% |
| 2023 | -0.97% | -104.31% |
| 2022 | 22.53% | -57.49% |
| 2021 | 53.00% | -15.34% |
| 2020 | 62.61% | 333.9% |
| 2019 | 14.43% | 18.89% |
| 2018 | 12.14% | -519.45% |
| 2017 | -2.89% | -65.78% |
| 2016 | -8.45% | 78.35% |
| 2015 | -4.74% | -20.52% |
| 2014 | -5.96% | -407.96% |
| 2013 | 1.94% | -60.37% |
| 2012 | 4.89% | -32.51% |
| 2011 | 7.24% | -147.11% |
| 2010 | -15.37% | -148.42% |
| 2009 | 31.74% | 36.63% |
| 2008 | 23.23% | 33.65% |
| 2007 | 17.38% | 22.62% |
| 2006 | 14.18% | -345.64% |
| 2005 | -5.77% | -386.72% |
| 2004 | 2.01% | -85.7% |
| 2003 | 14.08% | 85.09% |
| 2002 | 7.61% | 76.38% |
| 2001 | 4.31% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 | 16.31% | -121.30% | 🇺🇸 USA |
 | 9.46% | -112.35% | 🇺🇸 USA |
 | 16.41% | -121.43% | 🇺🇸 USA |
 | -8.61% | -88.76% | 🇺🇸 USA |
 | 19.45% | -125.39% | 🇺🇸 USA |
 | 14.13% | -118.45% | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.